Crayhon Research Now Available Exclusively Through Emerson... ( BEDFORD N.H. Oct. 1 /- Emerson Ecolog...)

Crayhon Research Now Available Exclusively Through Emerson Ecologics

Date:10/1/2009

BEDFORD, N.H., Oct. 1 /PRNewswire/ -- Emerson Ecologics, LLC announces a new strategic partnership with Crayhon Research as their exclusive distributor. Effective immediately, Emerson Ecologics will be handling all order fulfillment for the complete line of Crayhon Research products.

Crayhon Research designs and manufactures advanced nutritional supplements for the brain and body, available to patients solely through health care practitioners. By offering their line exclusively through Emerson, Crayhon will be able to focus more intently on its true mission: to create the highest quality products formulated with clinical efficacy using the latest in clinical research.

For nearly 30 years, Emerson Ecologics has worked with their supplier partners to provide the healthcare community with professional-grade supplements and unparalleled service. Crayhon Research customers will benefit from the partnership in numerous ways. Most notably, peer-to-peer counseling is available from Emerson's in-house Professional Services team of healthcare practitioners. There are also many other services offered for the convenience of providers, including Patient Ordering Service, Virtual Dispensary®, Auto Delivery, exclusive clinical research updates and a wealth of information online.

"Crayhon's commitment to high quality innovative products and exceptional ingredients are aligned with Emerson's objective to ensure that our practitioners and their patients have access to the safest and most effective products available," said Fran Towey, CEO of Emerson Ecologics. "We are pleased to be able to partner with a company such as Crayhon Research and look forward to serving their customers."

"In order to focus our efforts on bringing the best new supplements to market based on the latest research, we felt our customers would benefit the most by partnering with Emerson," said Michael Vierra, President and CEO of Crayhon Research. "We
'/>"/>

SOURCE Emerson Ecologics, LLC
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2
Related medicine news :

1. Stanford researchers find culprit in aging muscles that heal poorly
2. Children of depressed moms do better when dad is involved, SLU researcher finds
3. UCLA researchers identify markers that may predict diabetes in still-healthy people
4. Mayo Clinic researchers discover new diagnostic test for detecting infection in prosthetic joints
5. New research shows how chronic stress worsens neurodegenerative disease course
6. New research explores newborn in-hospital weight loss
7. Research may unlock mystery of autisms origin in the brain
8. Bipolar disorder relapses halved by Melbourne researchers
9. HIVs impact in Zimbabwe explored in new research
10. U.S. Research Funding Continues to Flatten as U.S. Health Costs Climb - in August 31 Science
11. Cell that triggers symptoms in allergy attacks can also limit damage, Stanford researchers find

Post Your Comments:

(Date:12/16/2009)... been found, , , WEDNESDAY, Dec. 16 (HealthDay News) -- ... food poisoning and the stomach pain and diarrhea that ... urinary tract infections. , Researchers have found the same ... restaurants and in women with the infections. , ... to the women through the food they ate, although ...

(Date:12/16/2009)... promote Massachusetts companies through annual marketing campaign , ... ... BioSpace unveiled the 2010 Genetown™ Hotbed Campaign as ... , ,Genetown is sponsored by MassBio and showcases ... The campaign places each entity’s brand on an electronic ...

(Date:12/16/2009)... also at all-time low, government report shows, , , WEDNESDAY, ... the United States has reached almost 78 years, a ... birth in 2007, women can expect to live to ... according to the report from the U.S. Centers for ... Americans can expect to live longer than their parents, ...

(Date:12/16/2009)... COLUMBIA, S.C., Dec. 16 Medical travel ... state-of-the-art hospitals in Puerto Rico into its network ... prices substantially lower than those at mainland U.S. ... will offer medical travel assistance and preferred pricing ... who seek treatment at either HIMA San Pablo ...

(Date:12/16/2009)... MassMutual,s Retirement Services Division has announced ... platform in Q2 2010. The new platform will ... investment change materials in a variety of themes. ... from a menu of creative options to support ... population. The new RetireSmart participant engagement platform will ...

Breaking Medicine News(10 mins):Health News:Foodborne E. Coli Suspected in Urinary Tract Infections 2 Health News:Foodborne E. Coli Suspected in Urinary Tract Infections 3 Health News:Thriving Bioscience Region Leaves Its Mark 2 Health News: Life Expectancy in U.S. Hits New High 2 Health News: Life Expectancy in U.S. Hits New High 3 Health News:Hospitals in Puerto Rico Join Companion Global Healthcare's Network 2 Health News:MassMutual to Launch New RetireSmart(SM) Participant Engagement Platform 2 Health News:MassMutual to Launch New RetireSmart(SM) Participant Engagement Platform 3 Health News:MassMutual to Launch New RetireSmart(SM) Participant Engagement Platform 4 Health News:MassMutual to Launch New RetireSmart(SM) Participant Engagement Platform 5

[0] Foodborne E. Coli Suspected in Urinary Tract Infections [0] Thriving Bioscience Region Leaves Its Mark [0] Life Expectancy in U.S. Hits New High [0] Hospitals in Puerto Rico Join Companion Global Healthcare's Network [0] MassMutual to Launch New RetireSmart(SM) Participant Engagement Platform

... MILLS, Md., Oct. 30 Medifast, Inc.,(NYSE: MED ) ... 2008 financial results for the period ended September 30, 2008 ... call and web,cast to discuss the results on Thursday, November ... the call by dialing (866) 524-3160 or,(412) 317-6760, or can ...

... as One of the Top 10 Most Interesting ... Oct. 30 Genaera,Corporation (NASDAQ: GENR ) ... being held November 3-5 at the Lowes Hotel ... and,Chief Scientific Officer, will provide an overview on ...

... Cardo Medical, a company engaged,in the development ... of its Align 360 Total Knee System. The ... release during the second quarter of 2009.,Cardo Medical,s ... within,its Align 360 platform which has already received ...

... 2009 Operating Preview, MELVILLE, N.Y., Oct. 30 ... a leading provider of comprehensive home,health services, today ... and 26% operating contribution growth from its Home ... clinical innovation, quality and,productivity to enhance its industry ...

... by SEIU,Secretary-Treasurer Anna Burger on Barack Obama,s prime-time special:, ... voters will head to the polls,to choose a president ... biggest economic crisis since the Great Depression., "Tonight, ... right now--tax cuts for the middle class, affordable,healthcare for ...

... and mobile devices with wireless connectivity. , ... ... a provider of clinical information for healthcare professionals, is pleased ... that delivers Lexi-Comp,s drug, disease, and formulary content on smartphones ...

Medifast, Inc. to Announce Third Quarter of Fiscal Year 2008 Financial Results on Thursday, November 6, 2008 Genaera to Present at Therapeutic Area Partnerships 2008 Cardo Medical Announces FDA Clearance of the Align 360 Total Knee System Gentiva Reports Third Quarter Revenue and Profit Growth Obama Puts Healthcare, Economic Relief for Middle Class First in Prime-Time Special Lexi-Comp Point-of-Care Information Now Available on Smartphones, Coming Soon for the iPhone™

(Date:12/16/2009)... A new application developed by American ... of specialty pharmaceuticals has increased health plan staff ... reducing costs. ,, AIM, a leading diagnostic imaging ... clients representing over 35 million consumers and an ... WLP ), adapted the successful clinical and technology ...

(Date:12/16/2009)... Technologies, Inc. (Pink Sheets: AVXT) ("AVAX" or the ... bridge loan financing (the "2009 Financing") pursuant to ... "Agreement") with Firebird Global Master Fund, Ltd., ("Firebird"). ... convertible promissory note, due June 30, 2010, in ... a warrant to purchase an aggregate of 93,333,333 ...

(Date:12/16/2009)... Dec. 16 Boston Scientific Corporation (NYSE: ... of Directors has elected Nelda Connors as a Director. ... the Electrical and Metal Products division of Tyco International. ... Corporation, holding several positions in operations and general management. ... a number of executive and management capacities with Ford, ...

Breaking Medicine Technology:American Imaging Management's New Specialty Drug Program Delivers Immediate Results 2 American Imaging Management's New Specialty Drug Program Delivers Immediate Results 3 American Imaging Management's New Specialty Drug Program Delivers Immediate Results 4 AVAX Technologies, Inc. Closes Bridge Financing 2 AVAX Technologies, Inc. Closes Bridge Financing 3 AVAX Technologies, Inc. Closes Bridge Financing 4 Boston Scientific Announces Election of Nelda Connors to Its Board of Directors 2 Boston Scientific Announces Election of Nelda Connors to Its Board of Directors 3 Savient Pharmaceuticals Reports Third Quarter 2009 Financial Results 6000 1 Savient Pharmaceuticals Reports Third Quarter 2009 Financial Results 6000 2 Savient Pharmaceuticals Reports Third Quarter 2009 Financial Results 6000 3 Savient Pharmaceuticals Reports Third Quarter 2009 Financial Results 6000 4 Savient Pharmaceuticals Reports Third Quarter 2009 Financial Results 6000 5 Savient Pharmaceuticals Reports Third Quarter 2009 Financial Results 6000 6 Savient Pharmaceuticals Reports Third Quarter 2009 Financial Results 6000 7 Savient Pharmaceuticals Reports Third Quarter 2009 Financial Results 6000 8 Savient Pharmaceuticals Reports Third Quarter 2009 Financial Results 6000 9 Savient Pharmaceuticals Reports Third Quarter 2009 Financial Results 6000 10 Savient Pharmaceuticals Reports Third Quarter 2009 Financial Results 6000 11 Savient Pharmaceuticals Reports Third Quarter 2009 Financial Results 6000 12 Savient Pharmaceuticals Reports Third Quarter 2009 Financial Results 6000 13 Savient Pharmaceuticals Reports Third Quarter 2009 Financial Results 6000 14 Professor Steven Ley of University of Cambridge will Present Free Webinar 26apos 3BApplication of the ReactIR Flow Cell to Continuous Processing Tec 14728 1 Professor Steven Ley of University of Cambridge will Present Free Webinar 26apos 3BApplication of the ReactIR Flow Cell to Continuous Processing Tec 14728 2 Professor Steven Ley of University of Cambridge will Present Free Webinar 26apos 3BApplication of the ReactIR Flow Cell to Continuous Processing Tec 14728 3 COTR Refresher Course Offered 11 January 2010 28Wash DC Area 29 60727 1 COTR Refresher Course Offered 11 January 2010 28Wash DC Area 29 60727 2 COTR Refresher Course Offered 11 January 2010 28Wash DC Area 29 60727 3

[0] American Imaging Management's New Specialty Drug Program Delivers Immediate Results [0] AVAX Technologies, Inc. Closes Bridge Financing [0] Boston Scientific Announces Election of Nelda Connors to Its Board of Directors

... Aug. 21 ,Bayer HealthCare Pharmaceuticals, Inc. and ... announced the companies have begun enrolling patients,in ... the Prevention of,Recurrence of Hepatocellular Carcinoma trial. ... evaluating Nexavar(R) (sorafenib),tablets as adjuvant treatment, which ...

... Aug. 20 Enobia Pharma, an emerging biotech,company ... today announced that the first patient in its ... investigating Enzyme,Replacement Therapy (ERT) with ENB-0040 for the ... disorder for which there is no approved,treatment., ...

Other Medicine Technology:Bayer and Onyx Begin Enrollment in STORM Trial Studying Nexavar as Adjuvant Therapy for Patients With Liver Cancer 2 Bayer and Onyx Begin Enrollment in STORM Trial Studying Nexavar as Adjuvant Therapy for Patients With Liver Cancer 3 Bayer and Onyx Begin Enrollment in STORM Trial Studying Nexavar as Adjuvant Therapy for Patients With Liver Cancer 4 Bayer and Onyx Begin Enrollment in STORM Trial Studying Nexavar as Adjuvant Therapy for Patients With Liver Cancer 5 Enobia Pharma Initiates Clinical Testing of Enzyme Replacement Therapy to Treat Hypophosphatasia 2 Enobia Pharma Initiates Clinical Testing of Enzyme Replacement Therapy to Treat Hypophosphatasia 3

Bayer and Onyx Begin Enrollment in STORM Trial Studying Nexavar as Adjuvant Therapy for Patients With Liver Cancer Enobia Pharma Initiates Clinical Testing of Enzyme Replacement Therapy to Treat Hypophosphatasia

... the durability of natural tissue ... of ingrowth and natural adaptation ... exceeds all applicable state and ... Tissue also reduces OR time ...

Meets the demanding requirements of most pelvic floor reconstructive procedures, and is highly resistant to suture pull-through, demonstrating long-term durability, and serves as a structural support...

... The FineTech-Brindley (also known as the ... which has been used by people with ... (or urinate) on demand. A secondary use ... bowel evacuation and promote penile erection.,The Bladder ...

... Nephrostomy Balloon is used to dilate the ... nephrostomy tract during a percutaneous procedure. The ... from the balloon to the catheter shaft ... close approximation of the dilating tract to ...

Medicine Products:

FasLata® Allograft Tissue Bard Dermal Allograft FineTech-Brindley (VOCARE) Bladder System Ultraxx Nephrostomy Balloon and Set

Crayhon Research Now Available Exclusively Through Emerson...( BEDFORD N.H. Oct. 1 /- Emerson Ecolog...),Health